-
IntroducedMar 31, 2023
-
Passed Senate
-
Passed House
-
Signed into Law
An Act relating to the Board of Pharmacy; relating to insurance; relating to pharmacies; relating to pharmacists; relating to pharmacy benefits managers; relating to patient choice of pharmacy; and providing for an effective date.
Last Action See all actions
Senate • Apr 17, 2024: (S) COSPONSOR(S): CLAMAN
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 121
Tweets
Whip Lists
Sponsors
- Tobincosponsor
- Gray-Jacksoncosponsor
- Clamancosponsor
Votes
Actions
- Apr 17, 2024 | Senate
- (S) COSPONSOR(S): CLAMAN
- Mar 20, 2024 | Senate
- (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)
- (S) Heard & Held
- Mar 11, 2024 | Senate
- (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)
- (S) Heard & Held
- Mar 06, 2024 | Senate
- (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)
- (S) Heard & Held
- (S) Minutes (SL&C)
- Feb 28, 2024 | Senate
- (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)
- (S) Heard & Held
- (S) Minutes (SL&C)
- Feb 27, 2024 | House
- (H) HEALTH & SOCIAL SERVICES at 03:00 PM DAVIS 106
- (H) Minutes (HHSS)
- Feb 08, 2024 | Senate
- (S) SPONSOR SUBSTITUTE INTRODUCED - REFERRALS
- (S) L&C, FIN
- (S) Referred to LABOR & COMMERCE
- (S) COSPONSOR(S): GRAY-JACKSON
- Jan 16, 2024 | Senate
- (S) COSPONSOR(S): MYERS, TOBIN
- Apr 05, 2023 | Senate
- (S) COSPONSOR(S): BJORKMAN
- Mar 31, 2023 | Senate
- (S) Read the first time - REFERRALS
- (S) L&C, FIN
Documents
- Sponsor Statement
- SENATE LABOR & COMMERCE 3/20/2024 (Audio/Video)
- SENATE LABOR & COMMERCE 3/11/2024 (Audio/Video)
- SENATE LABOR & COMMERCE 3/6/2024 (Minutes/Audio/Video)
- SENATE LABOR & COMMERCE 2/28/2024 (Minutes/Audio/Video)
- HOUSE HEALTH & SOCIAL SERVICES 2/27/2024 (Minutes/Audio/Video)
- SL&C 3/20/2024 -- SSSB121 Public Testimony ACPA 03.11.24.pdf
- SL&C 3/20/2024 -- SSSB121 Public Testimony-CVS Brenda Snyder 03.20.24.pdf
- SL&C 3/20/2024 -- SSSB121 Intro Slides Giessel 3-20-24.pdf
- SL&C 3/20/2024 -- SSSB121 Public Testimony Albertsons 03.19.24.pdf
- SL&C 3/20/2024 -- SSSB121 Public Testimony Nat. Psoriasis Foundation 03.15.24.pdf
- SL&C 3/20/2024 -- SSSB121 Public Testimony APRN Alliance 03.17.24.pdf
- SL&C 3/20/2024 -- SSSB121 Public Testimony-Dianne Holmes 03.14.24.pdf
- SL&C 3/20/2024 -- SSSB121 Mulready 10th Circuit Decision.pdf
- SL&C 3/20/2024 -- SSSB121 DCCED-DOI Applicable Court Cases in Oklahoma and Arkansas 03.12.24.pdf
- SL&C 3/20/2024 -- SSSB121 Public Testimony-Letter_PHC 03.09.24.pdf
- SL&C 3/20/2024 -- SSSB121 Public Testimony-Letter_NABIP 03.20.24.pdf
- HL&C 3/11/2024 -- SB121 & HB226 DCCED-DOI Applicable Court Cases in Oklahoma and Arkansas 3.12.24.pdf
- SL&C 3/11/2024 -- SSSB121 Public Testimony-Letter-Alaska UFCW 1496 03.01.24.pdf
- SL&C 3/11/2024 -- SSSB121 Presentation to SLAC by Greg Loudon 03.11.24.pdf
- SL&C 3/11/2024 -- SSSB121 Presentation to SLAC by Dan Nelson 03.11.24.pdf
- SL&C 3/11/2024 -- SSSB121 Supporting Document PCMA Bd of Directors 03.05.24.pdf
- SL&C 3/11/2024 -- SSSB121 Public Testimony-Letter-PCMA-03.07.24.pdf
- SL&C 3/11/2024 -- SSSB121 Public Testimony Petersburg Rexall Drug 02.26.24.pdf
- SL&C 3/11/2024 -- SSSB121 Bibliography.2 03-08-24.pdf
- SL&C 3/11/2024 -- SSSB121 Supporting Document-Stat News-Article-PBMs Stonewalling FTC 03.27.24.pdf
- SL&C 3/11/2024 -- SSSB121 Supporting Document-Stat News-Article-Big 3 Are Everything Wrong With Industry 03.04.24.pdf
- SL&C 3/11/2024 -- SSSB121 Supporting Document-One Pager AK Pharmacists Association 03.04.24.pdf
- SL&C 3/11/2024 -- SSSB121 Supporting Document-FIERCE Healthcare-Article-PBM Reform Still in Play 02.28.24.pdf
- SL&C 3/11/2024 -- SSSB121 Supporting Document PCMA Lobbying Spend AIS Health 02.15.24.pdf
- SL&C 3/11/2024 -- SSSB121 Supporting Document US Cmmttee on Oversight 03.01.23.pdf
- SL&C 3/6/2024 -- SSSB121 Public Testimony-Letter ANHB to Senator Giessel 02.28.24.pdf
- SL&C 3/6/2024 -- SSSB121 Public Testimony-Letter AETNA_CVS 03.05.24.pdf
- SL&C 3/6/2024 -- SSSB121 Public Testimony-Fred Meyer 03.04.24.pdf
- SL&C 3/6/2024 -- SSSB121 Public Testimony-NCPA 02.28.24.pdf
- SL&C 3/6/2024 -- SSSB121 Presentation-revised-03-05-24.pdf
- SL&C 3/6/2024 -- SSSB121 Supporting Document-Article_Ohio Capitol Journal 02.06.24 .pdf
- SL&C 3/6/2024 -- SSSB121 Public Testimony-Letter-Premera 03.01.24.pdf
- SL&C 3/6/2024 -- SSSB121 Public Testimony-Letter-Cigna 02.27.24 .pdf
- SL&C 2/28/2024 -- SSSB121 Bibliography 02-28-24.pdf
- SL&C 2/28/2024 -- SSSB121 Presentation -revised- to SLAC Seignemartin-Wetzel 02-28-24.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document The Hill 10.14.23.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document Ron's Apothecary closure 12.05.23.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document-STAT News Article-PBMs stonewalling FTC 03.27.24.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document-Medical World News Article 12.2022.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document-STAT News Article-FTC reverses support for PBMs 07.20.23 (1).pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document-AK Journal of Commerce Article 02.11.24.pdf
- SL&C 2/28/2024 -- SSSB121 Letters of Support 15 Batched 02.20.24.pdf
- SL&C 2/28/2024 -- SSSB121 Letter of Support Nelson 02.14.24.pdf
- SL&C 2/28/2024 -- SSSB121 Letter of Support Alaska Attorney General 02.20.24.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document PBM Consolidation chart.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document Ohio AG sues PBM 03.27.23.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document Lobbying group spends millions 07.18.23.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document FTC reverses support for PBMs 07.20.23.pdf
- SL&C 2/28/2024 -- SSSB121 Supporting Document FTC 05.17.23.pdf
- SL&C 2/28/2024 -- SSSB121 Support Emails Batch #2 02-26-24.pdf
- SL&C 2/28/2024 -- SSSB121 Support Emails as of 02.20.24.pdf
- SL&C 2/28/2024 -- SSSB121 Support Document-AKPHA Petition 02.20.24.pdf
- SL&C 2/28/2024 -- SSSB121 Public Testimony-Letter-PHC-Opposition 02.27.24 .pdf
- SL&C 2/28/2024 -- SSSB121 Public Testimony-Letter-Karen Miller-Support 02-22-24.pdf
- SL&C 2/28/2024 -- SSSB121 Public Testimony-Letter-ASCO 02.28.24.pdf
- SL&C 2/28/2024 -- SSSB121 Public Testimony-Letter-AHIP 02.27.24.pdf
- SL&C 2/28/2024 -- SSSB121 Public Testimony-Letter NACDS-Support 02-26-24.pdf
- SL&C 2/28/2024 SL&C 3/11/2024 SL&C 3/20/2024 -- SSSB121 Fiscal Note-DOA-DRB 02.24.24.pdf
- SL&C 2/28/2024 SL&C 3/11/2024 SL&C 3/20/2024 -- SSSB121 ver H.pdf
- SL&C 2/28/2024 SL&C 3/11/2024 SL&C 3/20/2024 -- SSSB121 Fiscal Note-DCCED-DOI-02.23.24.pdf
- SL&C 2/28/2024 SL&C 3/11/2024 SL&C 3/20/2024 -- SSSB121 Fiscal Note-DCCED-CBPL-02.23.24.pdf
- SL&C 2/28/2024 SL&C 3/11/2024 SL&C 3/20/2024 -- SSSB121 Sponsor Statement 02.11.24.pdf
- SL&C 2/28/2024 SL&C 3/11/2024 SL&C 3/20/2024 -- SSSB121 Sectional Analysis ver H 02.12.24.pdf